The arrival of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable excitement within the weight loss community. This novel dual GIP and GLP-1 agonist medication suggests to deliver notable improvements in fat reduction compared to existing therapies. Early research data have demonstrated substantial decreases in weight , potentially re